Dr.reddy's Laboratories Ltd — Metoprolol Exporter Profile
Indian Pharmaceutical Exporter · #5 for Metoprolol · $61.4M export value · DGFT Verified
Dr.reddy's Laboratories Ltd is the #5 Indian exporter of Metoprolol with $61.4M in export value and 1,241 verified shipments. Dr.reddy's Laboratories Ltd holds a 12.1% market share in Metoprolol exports across 7 countries.
Dr.reddy's Laboratories Ltd — Metoprolol Export Profile: Buyers & Destinations
Where Does Dr.reddy's Laboratories Ltd Export Metoprolol?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $26.5M | 789 | 57.2% |
| BRAZIL | $19.8M | 602 | 42.7% |
| GERMANY | $24.8K | 4 | 0.1% |
| NETHERLANDS | $22.5K | 1 | 0.0% |
| MAURITIUS | $9.8K | 1 | 0.0% |
| MALDIVES | $8.5K | 5 | 0.0% |
| CHILE | $4.0K | 3 | 0.0% |
Dr.reddy's Laboratories Ltd exports Metoprolol to 7 countries. The largest destination is UNITED STATES accounting for 57.2% of Dr.reddy's Laboratories Ltd's Metoprolol shipments, followed by BRAZIL (42.7%) and GERMANY (0.1%). These destinations reflect Dr.reddy's Laboratories Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Metoprolol from Dr.reddy's Laboratories Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| DR. REDDYS LABORATORIES, INC | UNITED STATES | $9.2M | 221 |
| NORTHSTAR DISTRIBUTION CENTER 8912 | UNITED STATES | $4.4M | 167 |
| BANCO SANT ANDER BRASIL SA | BRAZIL | $4.3M | 130 |
| SANOFI MEDLEY FARMACEUTICA LTDA | BRAZIL | $3.8M | 128 |
| DR REDDYS LABORATORIES,INC | UNITED STATES | $3.5M | 115 |
| PRIORITY HEALTHCARE DISTRIBUTION | UNITED STATES | $2.2M | 73 |
| BIOLAB SANUS FARMACEUTICA LTDA | BRAZIL | $1.8M | 73 |
| BIOLAB SANUS FARMACEUTICA | BRAZIL | $1.7M | 42 |
| SANOFI MEDLEY FARMACEUTICA LTDA., | BRAZIL | $1.7M | 36 |
| BIOLAB SANUS FARMACEUTICA LTD.A | BRAZIL | $1.6M | 34 |
Dr.reddy's Laboratories Ltd supplies Metoprolol to 47 buyers globally. The largest buyer is DR. REDDYS LABORATORIES, INC (UNITED STATES), followed by NORTHSTAR DISTRIBUTION CENTER 8912 (UNITED STATES) and BANCO SANT ANDER BRASIL SA (BRAZIL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Metoprolol Export Value and How Much Does Dr.reddy's Laboratories Ltd Contribute?
India exported $199.4M worth of Metoprolol through 10,118 shipments from 306 suppliers to 118 countries, serving 949 buyers globally. Dr.reddy's Laboratories Ltd contributes $61.4M to this total, accounting for 12.1% of India's Metoprolol exports. Dr.reddy's Laboratories Ltd ships Metoprolol to 7 countries through 47 buyers.
What Is the Average Shipment Value for Dr.reddy's Laboratories Ltd's Metoprolol Exports?
Dr.reddy's Laboratories Ltd's average Metoprolol shipment value is $49.5K per consignment, based on 1,241 shipments totaling $61.4M. The largest destination is UNITED STATES (57.2% of Dr.reddy's Laboratories Ltd's Metoprolol exports).
How Does Dr.reddy's Laboratories Ltd Compare to Other Indian Metoprolol Exporters?
Dr.reddy's Laboratories Ltd ranks #5 among 306 Indian Metoprolol exporters with a 12.1% market share. The top 3 exporters are DR.REDDY'S LABORATORIES LTD ($61.4M), RUBICON RESEARCH PRIVATE LIMITED ($26.6M), CIPLA LIMITED ($15.9M). Dr.reddy's Laboratories Ltd processed 1,241 shipments to 7 destination countries.
What Metoprolol Formulations Does Dr.reddy's Laboratories Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| METOPROLOL SUCCINATE EXTENDED-RELEASE TA | $9.9M | 228 |
| Succinato de metoprolol 50mg (30's Pack) | $999.9K | 21 |
| SUCCINATO DE METOPROLOL 25 MG (30S PACK) | $437.1K | 11 |
| 300031539 SUCCINATO DEMETOPROLOL50 MG (3 | $400.0K | 8 |
| 300031539 SUCCINATO DE METOPROLOL 50 MG(COMPRIMIDOS REVESTIDOS DE LIBERACAO CONTROLADA)(49392X30'S) | $350.3K | 13 |
| Succinato de metoprolol 25mg (30's Pack) | $347.6K | 11 |
| 300031538 SUCCINATO DE METOPROLOL 25 MG | $300.0K | 6 |
| 300031539 (SUCCINATO DE METOPROLOL 50MG( | $300.0K | 6 |
| SUCCINATO DE METOPROLOL 25MG(30'S PACK) | $288.6K | 9 |
| SUCCINATO DE METOPROLOL 50MG | $250.0K | 5 |
Dr.reddy's Laboratories Ltd exports 629 distinct Metoprolol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is METOPROLOL SUCCINATE EXTENDED-RELEASE TA with 228 shipments worth $9.9M.
Regulatory Requirements: Exporting Metoprolol to Key Markets
What Dr.reddy's Laboratories Ltd must comply with to export Metoprolol to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Brazil — ANVISA
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Germany — BfArM/EMA
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Dr.reddy's Laboratories Ltd Compare to Nearest Metoprolol Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | DR.REDDY'S LABORATORIES LTD ★ | $61.4M | 1,241 | 7 | $49.5K |
| 1 | RUBICON RESEARCH PRIVATE LIMITED | $26.6M | 532 | 2 | $50.0K |
| 2 | CIPLA LIMITED | $15.9M | 319 | 1 | $50.0K |
Dr.reddy's Laboratories Ltd ranks #5 among 306 Indian Metoprolol exporters. Average shipment value of $49.5K compared to the market average of $651.6K. The closest competitors by value are RUBICON RESEARCH PRIVATE LIMITED and CIPLA LIMITED.
Which Indian Ports Ship Metoprolol Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,639 | 16.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,096 | 10.8% |
| DELHI AIR CARGO ACC (INDEL4) | 932 | 9.2% |
| HYDERABAD ICD | 847 | 8.4% |
| DELHI AIR | 673 | 6.7% |
| HYDERABAD ICD (INSNF6) | 667 | 6.6% |
| NHAVA SHEVA SEA (INNSA1) | 599 | 5.9% |
| Bombay Air | 325 | 3.2% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Metoprolol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Metoprolol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Dr.reddy's Laboratories Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 1,405 individual customs records matching Dr.reddy's Laboratories Ltd exporting Metoprolol, covering 629 formulations to 7 countries via 47 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 118+ countries, 949+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Metoprolol Export Data from Dr.reddy's Laboratories Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Dr.reddy's Laboratories Ltd's Metoprolol exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Dr.reddy's Laboratories Ltd
Company Profile
0 products · $0 total trade · 0 categories
Metoprolol Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Dr.reddy's Laboratories Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Metoprolol. For current shipment-level data, contact TransData Nexus.